Childhood Cancer

You are here

Home » Grants » All grants tagged with "Glioma"

All grants tagged with "Glioma"

Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma
Oren Becher, MD & Robert Wechsler-Reya, PhD
Ann & Robert H. Lurie Children’s Hospital of Chicago
Innovation Grants, Awarded 2019
Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth
Mariella G. Filbin, MD/PhD
Dana-Farber Cancer Institute
Crazy 8 Pilots, Awarded 2019
Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy
Bakhos Tannous, PhD
Massachusetts General Hospital
Innovation Grants, Awarded 2018
Role of GRP78 and CRTAC1 in Glioma Invasion
Razina Aziz-Bose
Stanford University
POST Program Grants, Awarded 2018
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies
Paul Knoepfler, PhD
University of California, Davis Medical Center
Innovation Grants, Awarded 2017
Identifying Biomarkers for BRAFV600E Inhibitors to Enhance Therapeutic Responses in Pediatric Gliomas
Keerthana Sankar
University of California San Francisco
POST Program Grants, Awarded 2017
Testing mTOR Inhibition in NF1-driven Low Grade Glioma
Laurence Okeke
The Johns Hopkins University School of Medicine
POST Program Grants, Awarded 2017
Adoptive Cell Therapy Against Brain Stem Gliomas
Brandon Wummer
University of Florida
POST Program Grants, Awarded 2017
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus
Kevin Cassady, MD & Christopher Walker, PhD
Research Institute at Nationwide Children's Hospital
Innovation Grants, Awarded 2016
Genetically Engineered T Cells as Therapy for Pediatric Glioma
Giedre Krenciute, PhD
Baylor College of Medicine
Young Investigator Grants, Awarded 2016

Pages

All childhood cancer types

Featured Hero

Seth Walsh

Seth is spunky and can be friends with anyone. After being diagnosed with ALL, Seth endured countless trips out-of-state, four relapses, two CAR T-cell therapies, two bone marrow transplants, and one clinical trial. Today, Seth has reached remission!
Read more »